LP32685-7

Carisoprodol+Meprobamate

Active

Description

Carisoprodol (N-isopropylmeprobamate, Soma, ingredient of Soma Compound) is a carbamate derivative first synthesized in 1959 and used clinically as a muscle relaxant and sedative. Carisoprodol is known to be metabolized to meprobamate and hydroxyl-meprobamate.
Meprobamate is the major metabolite of carisoprodol, and is a CNS depressant in its own right, indicated for the management of anxiety disorders or for short-term treatment of anxiety symptoms. Use of these drugs begins with a prescription for muscular pain or anxiety, and abuse may develop for the sedative-hypnotic effects. Source: LOINC partner 1

Basic Part Properties

Part Name

Carisoprodol+Meprobamate

Part Display Name

Carisoprodol+Meprobamate

Part Type

Component (Describes the core component or analyte measured)

Created On

2003-10-23

Construct for LOINC Short Name

Carisoprodol+Meprob

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP32685-7

Language Variants Get Info

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.